GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
WEB1 day ago · CNN —. GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced ...
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
WEB1 day ago · Translate. GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was ...
British pharma giant GSK strikes $2.3 billion deal to put an end to ...
WEB1 day ago · British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
GSK shares jump on $2.2 billion Zantac settlement - Yahoo Finance
WEB1 day ago · Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits that claimed its discontinued ...
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
WEB1 day ago · Oct. 9, 2024. The British drug maker GSK said on Wednesday that it would pay up to $2.2 billion to settle most of the lawsuits filed against it by people who claim that they developed cancer after ...
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
WEB1 day ago · GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with a suspected carcinogen.. The cases represent about 93% of those against the company involving Zantac, GSK said Wednesday in a …
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
WEB22 hours ago · GSK GSK 4.94% shares top the Stoxx Europe 600 index on Thursday after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued ...
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement — …
WEB22 hours ago · Analysts at Jefferies had estimated the global Zantac liability at around $7 billion across all defendants, with GSK's potential share at between $2 billion and $3.5 billion. "Hence, dismissal of ...
Pharma giant GSK to pay $2.2 to settle Zantac lawsuits - BBC
WEB1 day ago · UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.
Statement: Zantac (ranitidine) litigation – settlement agreements ...
WEB2 days ago · GSK also confirms that it has reached an agreement in principle to pay a total of $70 million to resolve the Zantac qui tam complaint previously filed by Valisure. The agreement in principle is subject to final approval from the Department of Justice (the “ Qui Tam Settlement”). GSK has not admitted any liability in the State Courts ...